Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 5/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.58 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.40 |
| ▸ | FADS1 | O60427 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | AHR | P35869 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30366567 | 1.00 | CYP2A6 (0.58) | CYP2A6CYP1A2NR4A2TRPV1ADRA2A | |
| Propane SCHEMBL28860823 | 0.92 | CYP2A6 (0.50) | CYP2A6CYP1A2NR4A2TRPV1ADRA2A | |
| SCHEMBL145859 | 0.83 | CYP2A6 (0.68) | CYP2A6CYP1A2FADS1TSHRTDP1 | |
| SCHEMBL8208536 | 0.83 | CYP2A6 (0.68) | CYP2A6CYP1A2FADS1TSHRTDP1 | |
| SCHEMBL30366566 | 0.81 | CYP1A2 (0.58) | CYP2A6CYP1A2NR4A2FADS1TP53 | |
| SCHEMBL30366437 | 0.81 | CYP1A2 (0.58) | CYP2A6CYP1A2NR4A2FADS1TP53 | |
| SCHEMBL1780245 | 0.81 | CYP1A2 (0.58) | CYP2A6CYP1A2NR4A2FADS1TP53 | |
| SCHEMBL29972350 | 0.79 | CYP2A6 (0.62) | CYP2A6CYP1A2NR4A2ADRA2ACHEK1 | |
| SCHEMBL5668937 | 0.79 | CYP2A6 (0.62) | CYP2A6CYP1A2NR4A2ADRA2ACHEK1 | |
| SCHEMBL5411000 | 0.79 | CYP2A6 (0.52) | CYP2A6NR4A2CHEK1TP53AHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112259714-B | Solid-state battery composite electrode plate, preparation method thereof and solid-state battery comprising solid-state battery composite electrode plate | 东莞东阳光科研发有限公司 | 2022-12-27 | — | — | CN | claimed |
| CN-110767464-B | Super capacitor containing MOFs material and preparation method thereof | 东莞东阳光科研发有限公司 | 2022-07-08 | — | — | CN | claimed |
| CN-115991815-A | Halogenated modified prepared photoresist resin material and preparation method thereof | 中国科学院长春应用化学研究所 | 2023-04-21 | — | — | CN | disclosed |
| CN-112259714-B | Solid-state battery composite electrode plate, preparation method thereof and solid-state battery comprising solid-state battery composite electrode plate | 东莞东阳光科研发有限公司 | 2022-12-27 | — | — | CN | disclosed |
| CN-110767464-B | Super capacitor containing MOFs material and preparation method thereof | 东莞东阳光科研发有限公司 | 2022-07-08 | — | — | CN | disclosed |
| CN-113178341-B | Super capacitor based on MOFs material | 重庆文理学院 | 2022-03-25 | — | — | CN | disclosed |
| US-10793584-B2 | Naphthobischalcogenadiazole derivative and production method therefor | OSAKA UNIVERSITY (JP) | 2020-10-06 | — | — | US | disclosed |
| US-20190337966-A1 | NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR | OSAKA UNIVERSITY (JP) | 2019-11-07 | — | — | US | disclosed |
| EP-3564245-A1 | NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR | Osaka University (JP) | 2019-11-06 | — | — | EP | disclosed |
| WO-2018123207-A1 | NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR | 国立大学法人大阪大学 | 2018-07-05 | — | — | WO | disclosed |
| EP-1122746-B1 | Composition for film formation and insulating film | JSR CORP (JP) | 2004-09-22 | — | — | EP | disclosed |
| US-4758639-A | Process for production of vinyl polymer | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-19 | — | — | US | disclosed |
| US-4757124-A | Suspension or emulsion polymerizing vinyl chloride monomer or mixture of vinyl chloride with vinyl monomer copolymerizable therewith in reactor with walls coated with antiscaling compound containing dye or pigments | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 1988-07-12 | — | — | US | disclosed |
| CN-85107531-A | Process for producing vinyl chloride polymer | — | 1987-01-21 | — | — | CN | disclosed |
| EP-0172427-A2 | Process for production of vinyl chloride polymer | Shin-Etsu Chemical Co., Ltd. (JP) | 1986-02-26 | — | — | EP | disclosed |
| US-4356295-A | COORDINATION CATALYSTS | MITSUBISHI PETROCHEMICAL COMPANY LIMITED (JP) | 1982-10-26 | — | — | US | disclosed |
| EP-0001096-B1 | FLAME RETARDANT POLYCARBONATE BLENDS | Mobay Chemical Corporation (US) | 1982-04-14 | — | — | EP | disclosed |
| EP-0040863-A1 | Flame-retardant polycarbonate polyblends | Mobay Chemical Corporation (US) | 1981-12-02 | — | — | EP | disclosed |
| US-4174359-A | HALOGEN COMPOUND | MOBAY CHEMICAL CORPORATION (US) | 1979-11-13 | — | — | US | disclosed |
| EP-0001096-A2 | Flame retardant polycarbonate blends | Mobay Chemical Corporation (US) | 1979-03-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10793584-B2 | Naphthobischalcogenadiazole derivative and production method therefor | CYP24A1, CYP26B1, CYP21A2 | CYP2A6 96/4885CYP1A2 115/4885NR4A2 2855/4885 |
| US-20190337966-A1 | NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR | CYP24A1, CYP26B1, CYP21A2 | CYP2A6 96/4885CYP1A2 115/4885NR4A2 2855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.